Fibrin clot properties in acute ischemic stroke: relation to neurological deficit

Thrombosis Research

Volumn 125, Issue 4, 2010, Pages 357-361

  Undas, Anetta ^a   Slowik, Agnieszka ^a   Wolkow, Pawel ^a   Szczudlik, Andrzej ^a   Tracz, Wiesława ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

acute ischemic stroke; fibrin clot; neurological deficit

Indexed keywords

D DIMER; FIBRINOGEN; LIPOPROTEIN;

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBRIN CLOT; FIBRIN FORMATION; FIBRINOLYSIS; HUMAN; MALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL;

ACUTE DISEASE; AGED; BLOOD COAGULATION TESTS; FAMILY; FEMALE; FIBRIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; FIBRINOLYSIS; HUMANS; INTRACRANIAL THROMBOSIS; ISCHEMIA; MALE; MIDDLE AGED; PERMEABILITY; STROKE; THROMBOSIS;

EID: 77949567632     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.11.013     Document Type: Article

References (29)

1. Mosesson M.W. Fibrinogen and fibrin structure and functions. J Thromb Haemost 3 (2005) 1894-1904
2. Blinc A., Planinsic G., Keber D., Jarh O., Lahajnar G., Zidansek A., and Demsar F. Dependence of blood clot lysis on the mode of transport of urokinase into the clot - a magnetic resonance imagining study in vitro. Thromb Haemost 65 (1991) 549-552
3. Collet J.P., Lesty C., Montalescot G., and Weisel J.W. Dynamic changes of fibrin architecture during fibrin formation and intrinsic fibrinolysis of fibrin-rich clots. J Biol Chem 278 (2003) 21331-21335
4. Collet J.P., Park D., Lesty C., Soria J., Soria C., Montalescot G., and Weisel J.W. Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed. Dynamic and structural approaches by confocal microscopy. Arterioscler Thromb Vasc Biol 20 (2000) 1354-1361
5. Scott E.M., Ariëns R.A.S., and Grant P.J. Genetic and environmental determinants of fibrin structure and function. Relevance to clinical disease. Arterioscler Thromb Vasc Biol 24 (2004) 1558-1566
6. Undas A., and Zeglin M. Fibrin clot structure and cardiovascular disease. Vasc Dis Prevention 3 (2006) 99-106
7. Undas A., Szuldrzynski K., Stepien E., Zalewski J., Godlewski J., Pasowicz M., Tracz W., and Zmudka K. Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: Effects of inflammation and oxidative stress. Atherosclerosis 196 (2008) 551-557
8. Fatah K., Silveira A., Tornvall P., Karpe F., Blomback M., and Hamsten A. Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age. Thromb Haemost 76 (1996) 535-540
9. Collet J.P., Allali Y., Lesty C., Tanguy M.L., Silvain J., Ankri A., Blanchet B., Dumaine R., Gianetti J., Payot L., Weisel J.M., and Montalescot G. Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis. Arterioscler Thromb Vasc Biol 26 (2006) 2567-2573
10. Mills J.D., Ariëns R.A., Mansfield M.W., and Grant P.J. Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease. Circulation 106 (2002) 1938-1942
11. Dunn E.J., Ariëns R.A., and Grant P.J. The influence of type 2 diabetes on fibrin structure and function. Diabetologica 48 (2005) 1198-1206
12. Lisman T., de Groot P.G., Meijers J.C.M., and Rosendaal F.R. Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis. Blood 15 (2005) 1102-1105
13. Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ 54 (1976) 541-553
14. Adams Jr. H.P., Bendixen B., Kapelle L.J., Biller J., Love B.B., Gordon D.L., and Marsh III E.E. Classification of subtype of acute ischemic stroke-definitions for use in a multicenter clinical trial. TOAST. Trial of Org10172 in Acute Stroke Treatment. Stroke 24 (1993) 35-41
15. Brott T., Adams Jr. H.P., Olinger C.P., Marler J.R., Barsan W.G., Biller J., Spilker J., Holleran R., Eberle R., Hertzberg V., et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20 (1989) 864-870
16. van Swieten J.C., Koudstaal P.J., Visser M.C., Schouten H.J., and van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19 (1988) 604-607
17. Alberti K.G., and Zimmet P.Z. Definition, diagnosis, and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 (1998) 539-553
18. Undas A., Celinska-Lowenhoff M., Lowenhoff T., and Szczeklik A. Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease. J Thromb Haemost 4 (2006) 1029-1036
19. Williams S., Fatah K., Ivert T., and Blomback M. The effect of acetyl salicylic acid on fibrin gel lysis by tissue plasminogen activator. Blood Coagul Fibrinolysis 6 (1995) 718-725
20. Bajzar L., Fredenburgh J.C., and Nesheim M. The activated protein C-mediated enhancement of tissue-type plasminogen activator-induced fibrinolysis in a cell-free system. J Biol Chem 265 (1990) 16948-16954
21. Collet J.-P., Mishal Z., Lesty C., Mirshahi M., Peyne J., Baumelou A., Bensman A., Soria J., and Soria C. Abnormal fibrin clot architecture in nephritic patients is related to hypofibrinolysis: influence of plasma biochemical modifications. Thromb Haemost 82 (1999) 1482-1489
22. Turgut N., Akdemir O., Turgut B., Demir M., Ekuklu G., Vural O., Ozbay G., and Utku U. Hypercoagulopathy in stroke patients with nonvalvular atrial fibrillation: hematologic and cardiologic investigations. Clin Appl Thromb Hemost 12 (2006) 15-20
23. Blombäck B., Carlsson K., Hessel B., Liljeborg A., Procyk R., and Aslund N. Native fibrin gel networks observed by 3D microscopy, permeation and turbidity. Biochim Biophys Acta 997 (1989) 96-110
24. Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 294 (2005) 1799-1809
25. Undas A., Stepien E., Tracz W., and Szczeklik A. Lipoprotein(a) as a modifier of fibrin clot permeability and susceptibility to lysis. J Thromb Haemost 4 (2006) 973-975
26. Milionis H.J., Filippatos T.D., Loukas T., Bairaktari E.T., Tselepis A.D., and Elisaf M.S. Serum lipoprotein(a) levels and apolipoprotein(a) isoform size and risk for first-ever acute ischaemic nonembolic stroke in elderly individuals. Atherosclerosis 187 (2006) 170-176
27. Undas A., Podolec P., Zawilska K., Pieculewicz M., Jedlinski I., Stepien E., Konarska-Kuszewska E., We{ogonek}glarz P., Duszyńska M., Hanschke E., Przewłocki T., and Tracz W. Altered fibrin clot structure is associated with stroke in patients with patent foramen ovale. Stroke 40 (2009) 1499-1501
28. Sjoland J.A., Sidelmann J.J., Brabrand M., Brabrand M., Pedersen R.S., Pedersen J.H., Esbensen K., Standeven K.F., Ariens R.A.S., and Gram J. Fibrin clot structure in patients with end-stage renal disease. Thromb Haemost 98 (2007) 339-345
29. Undas A., Brozek J., Jankowski M., Siudak Z., Szczeklik A., and Jakubowski H. Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects. Arterioscler Thromb Vasc Biol 26 (2006) 1397-1404